Upload Avatar (500 x 500)
Jiajun Fan
jiajunfan12@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Pharmaceutical Sciences
  • 2012.09 – 2016.07 PhD in Biosynthetic Medicinal Chemistry: Fudan University
  • 2009.09 – 2012.07 MSc in Biochemistry and Molecular Biology: Tongji University
  • 2004.09 – 2008.07 BSc in Biotechnology: Tongji University
  • 2019.07 – Present - Fudan University - Assistant Researcher
  • 2016.09 – 2019.05 - Fudan University - Postdoctoral Researcher
  • 2019: Fudan University Talent Introduction Project (500,000 RMB)
  • 2018: National Natural Science Foundation Youth Science Fund Project (210,000 RMB)
  • 2018: China Postdoctoral Fund Special Grant (150,000 RMB)
  • 2017: China Postdoctoral Fund General Grant (50,000 RMB)
Research on new strategies for immunotherapy of tumors and cardiovascular diseases
Research and development of innovative immunotherapy biopharmaceuticals
  • Regulating autophagy facilitated therapeutic efficacy of the sonic Hedgehog pathway inhibition on lung adenocarcinoma through GLI2 suppression and ROS production, Fan J, Zhang X, Wang S, Chen W, Li Y, Zeng X, Wang Y, Luan J, Li L, Wang Z, Sun X, Shen B, Ju D, 2019
  • Lysosomal dysfunction promotes Quantum Dots-induced Nanotoxicity through eliciting autophagy and ROS, Fan J, Wang S, Zhang X, Chen W, Li Y, Yang P, Cao Z, Wang Y, Lu W, Ju D, 2018
  • Inhibition of Autophagy Overcomes the Nanotoxicity Elicited by Cadmium-based Quantum Dots, Fan J, Sun Y, Wang S, Li Y, Zeng X, Cao Z, Yang P, Song P, Wang Z, Xian Z, Gao H, Chen Q, Cui D, Ju D, 2016
  • Targeting CD47 and autophagy elicited enhanced anti-tumor effects in non-small cell lung cancer, Zhang X, Fan J, Wang S, Li Y, Wang Y, Tian W, Song L, Luan J, Wang Z, Song P, Chen Q, Ju D, 2017
  • Tethering Interleukin-22 to apolipoprotein A-I ameliorates mice from acetaminophen-induced liver injury, Chen W, Zhang X, Fan J, Zai W, Luan J, Li Y, Wang S, Chen Q, Wang Y, Liang Y, Ju D, 2017
Immunotherapy Tumors Cardiovascular Diseases Biopharmaceuticals Research Development Innovative Strategies Therapy Diseases

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.